Johannes R. Streffer

Janssen R&D
Beerse, VLG, Belgium

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 83 publications

Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.

Cerebrospinal fluid proteome alterations related to depressive symptoms in cognitive decline and Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: September 23, 2025

Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.

Tumor-associated epilepsy and high expression of xCT shape the proteome of IDH-wildtype glioblastoma.

Journal: Cell death discovery
Published: August 18, 2025

Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.

Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: June 02, 2025

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.

The association of diabetes with Alzheimer's disease biomarkers and vascular burden across European aging and memory clinic cohorts.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 10, 2025

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study.

Safety and immunogenicity of two Tau-targeting active immunotherapies, ACI-35.030 and JACI-35.054, in participants with early Alzheimer's disease: a phase 1b/2a, multicentre, double-blind, randomised, placebo-controlled study.

Journal: EBioMedicine
Published: February 20, 2025

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Journal: Research square
Published: August 07, 2024

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Synaptic protein CSF levels relate to memory scores in individuals without dementia.

Journal: Alzheimer's research & therapy
Published: June 19, 2024

Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology.

Cerebrospinal fluid proteomic profiling of cognitively unimpaired individuals with suspected non-Alzheimer's disease pathophysiology.

Journal: Brain communications
Published: May 30, 2024

Facilitating the use of the target product profile in academic research: a systematic review.

Facilitating the use of the target product profile in academic research: a systematic review.

Journal: Journal of translational medicine
Published: May 13, 2024

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.

Involvement of the choroid plexus in Alzheimer's disease pathophysiology: findings from mouse and human proteomic studies.

Journal: Fluids and barriers of the CNS
Published: April 15, 2024

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association
Published: April 03, 2024

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

Paired plasma lipidomics and proteomics analysis in the conversion from mild cognitive impairment to Alzheimer's disease.

Journal: Computers in biology and medicine
Published: January 04, 2024
Showing 1-12 of 83

Last Updated: 09/26/2026